Amlitelimab | Interleukin Related interleukin-related.com

Product Name :
Amlitelimab

Search keywords :
OX40L

drugId :
null

Target Vo:
Tumor necrosis factor ligand superfamily member 4

Target Vo Short Name :
OX40L

Moa_Name:
Tumor necrosis factor ligand superfamily member 4 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Kymab Ltd

Active Company_Name :
Genzyme Ireland Ltd

Active Indication_Name:
Dermatitis, Atopic

In Active Indication_Name:
Immune System Diseases

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Atg12 Antibody
Phospho-PDGFR beta (Y740) Antibody
CD73 Antibody (YA528): CD73 Antibody (YA528) is a non-conjugated and Rabbit origined monoclonal antibody about 63 kDa, targeting to CD73. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts